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Appendix 3. Descriptions of unintentional discrepancies (part 1 of 2)
                                                                                                                                  Unintentional Discrepancies
Patient No.             Patients’ Medications                                                                  Description                                                 Classification†
                                  before Admission*
Baseline phase (medication reconciliation by nurse or pharmacist)
1                 • Atorvastatin                                  • Ferrous fumarate 30 mg (elemental iron) PO daily to be continued  Class I
                   • Ezetimibe                                      as per BPMH but ordered as bid. Patient took ferrous sulfate
                   • Clopidogrel                                   60 mg (elemental iron) PO daily at home. 
                   • Acetylsalicylic acid                         • Clopidogrel 15.6 mg PO daily ordered as per BPMH.                        Class I
                   • Ferrous sulfate                               Patient took 15.5 mg PO daily at home.
                   • Flintstones multivitamin
2                 • Furosemide                                   • Spironolactone 25 mg PO bid was ordered as per BPMH but           Class II
                   • Omeprazole                                  upon clarification, it was identified that patient took once
                   • Budesonide nebules                      daily at home.
                   • Budesonide oral liquid                   • Calcium carbonate 250 mg (elemental calcium) PO TID was            Class I
                   • Sildenafil                                       ordered as per BPMH, but upon clarification, patient took
                   • Spironolactone                              600 mg (elemental calcium) PO daily at home (2 discrepancies:
                   • Enalapril                                        wrong dose and wrong frequency).
                   • Dornase alfa                                  • Cholecalciferol 400 IU PO daily was ordered as per BPMH,              Class I
                   • Calcium carbonate                        but upon clarification, patient took 1000 IU PO daily at home.
                   • Cholecalciferol
3                 • Captopril                                       • Saline nasal drops, 1 drop in each nostril tid prn omitted                 Class I
                   • Furosemide                                   on BPMH.
                   • Saline nasal drops
4                 • Adenosine                                     • Adenosine 0.4 mg IV × 3 doses omitted on BPMH. Patient              Class I
                   • Glycerin infant suppository            received 3 doses at peripheral hospital.
                   • Cholecalciferol                               • Glycerin infant supp PR × 1 omitted on BPMH.                                Class I
5                 • Haliborange multivitamin liquid    • Haliborange multivitamin 2.5–5 mL PO once daily omitted              Class I
                                                                           on BPMH.
6                 • Flintstones multivitamin                 • Patient took Flintstones multivitamin 1 tablet PO daily alternating    Class I
                   • Gummy multivitamin                    with gummy multivitamin on different days at home. 
                                                                           Flintstones multivitamin omitted on BPMH.   
7                 • Furosemide                                   • Cholecalciferol 400 IU PO daily omitted on BPMH.                           Class I
                   • Cholecalciferol
8                 • Tacrolimus                                     • Zinc oxide 16% topical paste prn for diaper rash                             Class I 
                   • Mycophenolate mofetil                 (variable frequency as per parents) omitted on BPMH.
                   • Lorazepam                                    • Ferrous sulfate 39 mg (elemental iron) PO bid omitted on BPMH.    Class I
                   • Ferrous sulfate
                   • Citrate
                   • Hydrocortisone 1% cream
                   • Zinc oxide 16% paste
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Appendix 3. Descriptions of unintentional discrepancies (part 2 of 2)
                                                                                                                                  Unintentional Discrepancies
Patient No.             Patients’ Medications                                                                  Description                                                 Classification†
                                  before Admission*
Pilot phase ( medication reconciliation by pharmacy technician)
1                 • Levothyroxine                                Vitamin B12 1 tablet PO daily omitted on BPMH (dose unknown         Class I
                   • Calcium (salt unknown)                after attempts to determine). 
                   • Ferrous gluconate
                   • Cholecalciferol
                   • Vitamin B12
                   • Omega 3
2                 • Atomoxetine                                 Melatonin 1.5 mg PO qhs to continue as per BPMH                           Class I
                   • Fluvoxamine                                  but was not ordered.
                   • Melatonin
                   • Multivitamin
                   • Polyethylene glycol 3350
3                 • Flecainide                                      Nitrofurantoin 6 mg PO daily recorded on BPMH and ordered            Class I
                   • Sotalol                                           to start the following day. Patient took nitrofurantoin
                   • Lansoprazole                                 12 mg PO daily at home.
                   • Hydrochlorothiazide
                   • Nitrofurantoin
                   • Sucralfate
BPMH = best possible medication history.
*As listed in BPMH.
†Class I: unlikely to cause patient discomfort or clinical deterioration; class II, having potential to cause moderate discomfort 
or clinical deterioration; class III, having potential to cause severe discomfort or clinical deterioration.
